Literature DB >> 15211100

Percutaneous coronary intervention in diabetics.

Juhana Karha1, Deepak L Bhatt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15211100     DOI： 10.1023/B:REMD.0000032417.33194.09

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  120 in total

Review 1.  Contrast nephropathy.

Authors:  Sean W Murphy; Brendad J Barrett; Patrick S Parfrey
Journal:  J Am Soc Nephrol       Date:  2000-01       Impact factor: 10.121

2.  Problem of angioplasty in diabetics.

Authors:  S G Ellis; C R Narins
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

3.  Differential influence of diabetes mellitus on increased jeopardized myocardium after initial angioplasty or bypass surgery: bypass angioplasty revascularization investigation.

Authors:  Kevin E Kip; Edwin L Alderman; Martial G Bourassa; Maria Mori Brooks; Leonard Schwartz; David R Holmes; Robert M Califf; Patrick L Whitlow; Bernard R Chaitman; Katherine M Detre
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

Review 4.  Why diabetics are at risk in percutaneous coronary intervention and the appropriate management of diabetics in interventional cardiology.

Authors:  Joel P Reginelli; Deepak L Bhatt
Journal:  J Invasive Cardiol       Date:  2002-12       Impact factor: 2.022

5.  Relation of inflammation and benefit of statins after percutaneous coronary interventions.

Authors:  Albert W Chan; Deepak L Bhatt; Derek P Chew; Joel Reginelli; Jakob P Schneider; Eric J Topol; Stephen G Ellis
Journal:  Circulation       Date:  2003-03-24       Impact factor: 29.690

6.  Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials.

Authors:  H C Bucher; P Hengstler; C Schindler; G H Guyatt
Journal:  BMJ       Date:  2000-07-08

7.  Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty.

Authors:  G W Barsness; E D Peterson; E M Ohman; C L Nelson; E R DeLong; J G Reves; P K Smith; R D Anderson; R H Jones; D B Mark; R M Califf
Journal:  Circulation       Date:  1997-10-21       Impact factor: 29.690

8.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

9.  The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group.

Authors:  P H Stone; J E Muller; T Hartwell; B J York; J D Rutherford; C B Parker; Z G Turi; H W Strauss; J T Willerson; T Robertson
Journal:  J Am Coll Cardiol       Date:  1989-07       Impact factor: 24.094

10.  Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients.

Authors:  H Knobler; N Savion; B Shenkman; S Kotev-Emeth; D Varon
Journal:  Thromb Res       Date:  1998-05-15       Impact factor: 3.944
View more
  2 in total

1.  Enhanced proliferation and migration of vascular smooth muscle cells in response to vascular injury under hyperglycemic conditions is controlled by beta3 integrin signaling.

Authors:  Manikandan Panchatcharam; Sumitra Miriyala; Fanmuyi Yang; Michael Leitges; Magdalena Chrzanowska-Wodnicka; Lawrence A Quilliam; Paul Anaya; Andrew J Morris; Susan S Smyth
Journal:  Int J Biochem Cell Biol       Date:  2010-02-23       Impact factor: 5.085

Review 2.  Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization.

Authors:  Clarissa Cola; Salvatore Brugaletta; Victoria Martín Yuste; Bieito Campos; Dominick J Angiolillo; Manel Sabaté
Journal:  Vasc Health Risk Manag       Date:  2009-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.